Global RNA Modifying Agents Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
According to our (Global Info Research) latest study, the global RNA Modifying Agents market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
RNA modifications refer to various chemical modifications added to RNA molecules, which affect the function, stability and expression of RNA. RNA modifications play an important role in the regulation of gene expression, RNA processing and translation. There are many types of RNA modifications, and the content and function of different types of RNA modifications vary greatly. Among them, methylation modification is one of the main forms of RNA modification. This report mainly studies RNA methylation modification.
This report is a detailed and comprehensive analysis for global RNA Modifying Agents market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global RNA Modifying Agents market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global RNA Modifying Agents market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global RNA Modifying Agents market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global RNA Modifying Agents market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for RNA Modifying Agents
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global RNA Modifying Agents market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Active Motif, Epigentek, Thermo Fisher Scientific, Merck, Gene Link, abcam, ABclonal, MyBioSource, Beyotime, Hologic, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
RNA Modifying Agents market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe RNA Modifying Agents product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of RNA Modifying Agents, with price, sales quantity, revenue, and global market share of RNA Modifying Agents from 2020 to 2025.
Chapter 3, the RNA Modifying Agents competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the RNA Modifying Agents breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and RNA Modifying Agents market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of RNA Modifying Agents.
Chapter 14 and 15, to describe RNA Modifying Agents sales channel, distributors, customers, research findings and conclusion.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
RNA modifications refer to various chemical modifications added to RNA molecules, which affect the function, stability and expression of RNA. RNA modifications play an important role in the regulation of gene expression, RNA processing and translation. There are many types of RNA modifications, and the content and function of different types of RNA modifications vary greatly. Among them, methylation modification is one of the main forms of RNA modification. This report mainly studies RNA methylation modification.
This report is a detailed and comprehensive analysis for global RNA Modifying Agents market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global RNA Modifying Agents market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global RNA Modifying Agents market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global RNA Modifying Agents market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global RNA Modifying Agents market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for RNA Modifying Agents
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global RNA Modifying Agents market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Active Motif, Epigentek, Thermo Fisher Scientific, Merck, Gene Link, abcam, ABclonal, MyBioSource, Beyotime, Hologic, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
RNA Modifying Agents market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- N6-Methyladenosine (m6A) Antibody
- 5-Methylcytosine (5-mC) Antibody
- Others
- Gene Therapy
- Cancer Research
- Drug Development
- Other
- Active Motif
- Epigentek
- Thermo Fisher Scientific
- Merck
- Gene Link
- abcam
- ABclonal
- MyBioSource
- Beyotime
- Hologic
- Synaptic Systems
- Novus Biologicals
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe RNA Modifying Agents product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of RNA Modifying Agents, with price, sales quantity, revenue, and global market share of RNA Modifying Agents from 2020 to 2025.
Chapter 3, the RNA Modifying Agents competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the RNA Modifying Agents breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and RNA Modifying Agents market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of RNA Modifying Agents.
Chapter 14 and 15, to describe RNA Modifying Agents sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global RNA Modifying Agents Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 N6-Methyladenosine (m6A) Antibody
1.3.3 5-Methylcytosine (5-mC) Antibody
1.3.4 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global RNA Modifying Agents Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Gene Therapy
1.4.3 Cancer Research
1.4.4 Drug Development
1.4.5 Other
1.5 Global RNA Modifying Agents Market Size & Forecast
1.5.1 Global RNA Modifying Agents Consumption Value (2020 & 2024 & 2031)
1.5.2 Global RNA Modifying Agents Sales Quantity (2020-2031)
1.5.3 Global RNA Modifying Agents Average Price (2020-2031)
2 MANUFACTURERS PROFILES
2.1 Active Motif
2.1.1 Active Motif Details
2.1.2 Active Motif Major Business
2.1.3 Active Motif RNA Modifying Agents Product and Services
2.1.4 Active Motif RNA Modifying Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Active Motif Recent Developments/Updates
2.2 Epigentek
2.2.1 Epigentek Details
2.2.2 Epigentek Major Business
2.2.3 Epigentek RNA Modifying Agents Product and Services
2.2.4 Epigentek RNA Modifying Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Epigentek Recent Developments/Updates
2.3 Thermo Fisher Scientific
2.3.1 Thermo Fisher Scientific Details
2.3.2 Thermo Fisher Scientific Major Business
2.3.3 Thermo Fisher Scientific RNA Modifying Agents Product and Services
2.3.4 Thermo Fisher Scientific RNA Modifying Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Thermo Fisher Scientific Recent Developments/Updates
2.4 Merck
2.4.1 Merck Details
2.4.2 Merck Major Business
2.4.3 Merck RNA Modifying Agents Product and Services
2.4.4 Merck RNA Modifying Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Merck Recent Developments/Updates
2.5 Gene Link
2.5.1 Gene Link Details
2.5.2 Gene Link Major Business
2.5.3 Gene Link RNA Modifying Agents Product and Services
2.5.4 Gene Link RNA Modifying Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Gene Link Recent Developments/Updates
2.6 abcam
2.6.1 abcam Details
2.6.2 abcam Major Business
2.6.3 abcam RNA Modifying Agents Product and Services
2.6.4 abcam RNA Modifying Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 abcam Recent Developments/Updates
2.7 ABclonal
2.7.1 ABclonal Details
2.7.2 ABclonal Major Business
2.7.3 ABclonal RNA Modifying Agents Product and Services
2.7.4 ABclonal RNA Modifying Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 ABclonal Recent Developments/Updates
2.8 MyBioSource
2.8.1 MyBioSource Details
2.8.2 MyBioSource Major Business
2.8.3 MyBioSource RNA Modifying Agents Product and Services
2.8.4 MyBioSource RNA Modifying Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 MyBioSource Recent Developments/Updates
2.9 Beyotime
2.9.1 Beyotime Details
2.9.2 Beyotime Major Business
2.9.3 Beyotime RNA Modifying Agents Product and Services
2.9.4 Beyotime RNA Modifying Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 Beyotime Recent Developments/Updates
2.10 Hologic
2.10.1 Hologic Details
2.10.2 Hologic Major Business
2.10.3 Hologic RNA Modifying Agents Product and Services
2.10.4 Hologic RNA Modifying Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 Hologic Recent Developments/Updates
2.11 Synaptic Systems
2.11.1 Synaptic Systems Details
2.11.2 Synaptic Systems Major Business
2.11.3 Synaptic Systems RNA Modifying Agents Product and Services
2.11.4 Synaptic Systems RNA Modifying Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 Synaptic Systems Recent Developments/Updates
2.12 Novus Biologicals
2.12.1 Novus Biologicals Details
2.12.2 Novus Biologicals Major Business
2.12.3 Novus Biologicals RNA Modifying Agents Product and Services
2.12.4 Novus Biologicals RNA Modifying Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 Novus Biologicals Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: RNA MODIFYING AGENTS BY MANUFACTURER
3.1 Global RNA Modifying Agents Sales Quantity by Manufacturer (2020-2025)
3.2 Global RNA Modifying Agents Revenue by Manufacturer (2020-2025)
3.3 Global RNA Modifying Agents Average Price by Manufacturer (2020-2025)
3.4 Market Share Analysis (2024)
3.4.1 Producer Shipments of RNA Modifying Agents by Manufacturer Revenue ($MM) and Market Share (%): 2024
3.4.2 Top 3 RNA Modifying Agents Manufacturer Market Share in 2024
3.4.3 Top 6 RNA Modifying Agents Manufacturer Market Share in 2024
3.5 RNA Modifying Agents Market: Overall Company Footprint Analysis
3.5.1 RNA Modifying Agents Market: Region Footprint
3.5.2 RNA Modifying Agents Market: Company Product Type Footprint
3.5.3 RNA Modifying Agents Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global RNA Modifying Agents Market Size by Region
4.1.1 Global RNA Modifying Agents Sales Quantity by Region (2020-2031)
4.1.2 Global RNA Modifying Agents Consumption Value by Region (2020-2031)
4.1.3 Global RNA Modifying Agents Average Price by Region (2020-2031)
4.2 North America RNA Modifying Agents Consumption Value (2020-2031)
4.3 Europe RNA Modifying Agents Consumption Value (2020-2031)
4.4 Asia-Pacific RNA Modifying Agents Consumption Value (2020-2031)
4.5 South America RNA Modifying Agents Consumption Value (2020-2031)
4.6 Middle East & Africa RNA Modifying Agents Consumption Value (2020-2031)
5 MARKET SEGMENT BY TYPE
5.1 Global RNA Modifying Agents Sales Quantity by Type (2020-2031)
5.2 Global RNA Modifying Agents Consumption Value by Type (2020-2031)
5.3 Global RNA Modifying Agents Average Price by Type (2020-2031)
6 MARKET SEGMENT BY APPLICATION
6.1 Global RNA Modifying Agents Sales Quantity by Application (2020-2031)
6.2 Global RNA Modifying Agents Consumption Value by Application (2020-2031)
6.3 Global RNA Modifying Agents Average Price by Application (2020-2031)
7 NORTH AMERICA
7.1 North America RNA Modifying Agents Sales Quantity by Type (2020-2031)
7.2 North America RNA Modifying Agents Sales Quantity by Application (2020-2031)
7.3 North America RNA Modifying Agents Market Size by Country
7.3.1 North America RNA Modifying Agents Sales Quantity by Country (2020-2031)
7.3.2 North America RNA Modifying Agents Consumption Value by Country (2020-2031)
7.3.3 United States Market Size and Forecast (2020-2031)
7.3.4 Canada Market Size and Forecast (2020-2031)
7.3.5 Mexico Market Size and Forecast (2020-2031)
8 EUROPE
8.1 Europe RNA Modifying Agents Sales Quantity by Type (2020-2031)
8.2 Europe RNA Modifying Agents Sales Quantity by Application (2020-2031)
8.3 Europe RNA Modifying Agents Market Size by Country
8.3.1 Europe RNA Modifying Agents Sales Quantity by Country (2020-2031)
8.3.2 Europe RNA Modifying Agents Consumption Value by Country (2020-2031)
8.3.3 Germany Market Size and Forecast (2020-2031)
8.3.4 France Market Size and Forecast (2020-2031)
8.3.5 United Kingdom Market Size and Forecast (2020-2031)
8.3.6 Russia Market Size and Forecast (2020-2031)
8.3.7 Italy Market Size and Forecast (2020-2031)
9 ASIA-PACIFIC
9.1 Asia-Pacific RNA Modifying Agents Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific RNA Modifying Agents Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific RNA Modifying Agents Market Size by Region
9.3.1 Asia-Pacific RNA Modifying Agents Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific RNA Modifying Agents Consumption Value by Region (2020-2031)
9.3.3 China Market Size and Forecast (2020-2031)
9.3.4 Japan Market Size and Forecast (2020-2031)
9.3.5 South Korea Market Size and Forecast (2020-2031)
9.3.6 India Market Size and Forecast (2020-2031)
9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
9.3.8 Australia Market Size and Forecast (2020-2031)
10 SOUTH AMERICA
10.1 South America RNA Modifying Agents Sales Quantity by Type (2020-2031)
10.2 South America RNA Modifying Agents Sales Quantity by Application (2020-2031)
10.3 South America RNA Modifying Agents Market Size by Country
10.3.1 South America RNA Modifying Agents Sales Quantity by Country (2020-2031)
10.3.2 South America RNA Modifying Agents Consumption Value by Country (2020-2031)
10.3.3 Brazil Market Size and Forecast (2020-2031)
10.3.4 Argentina Market Size and Forecast (2020-2031)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa RNA Modifying Agents Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa RNA Modifying Agents Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa RNA Modifying Agents Market Size by Country
11.3.1 Middle East & Africa RNA Modifying Agents Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa RNA Modifying Agents Consumption Value by Country (2020-2031)
11.3.3 Turkey Market Size and Forecast (2020-2031)
11.3.4 Egypt Market Size and Forecast (2020-2031)
11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
11.3.6 South Africa Market Size and Forecast (2020-2031)
12 MARKET DYNAMICS
12.1 RNA Modifying Agents Market Drivers
12.2 RNA Modifying Agents Market Restraints
12.3 RNA Modifying Agents Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of RNA Modifying Agents and Key Manufacturers
13.2 Manufacturing Costs Percentage of RNA Modifying Agents
13.3 RNA Modifying Agents Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 RNA Modifying Agents Typical Distributors
14.3 RNA Modifying Agents Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global RNA Modifying Agents Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 N6-Methyladenosine (m6A) Antibody
1.3.3 5-Methylcytosine (5-mC) Antibody
1.3.4 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global RNA Modifying Agents Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Gene Therapy
1.4.3 Cancer Research
1.4.4 Drug Development
1.4.5 Other
1.5 Global RNA Modifying Agents Market Size & Forecast
1.5.1 Global RNA Modifying Agents Consumption Value (2020 & 2024 & 2031)
1.5.2 Global RNA Modifying Agents Sales Quantity (2020-2031)
1.5.3 Global RNA Modifying Agents Average Price (2020-2031)
2 MANUFACTURERS PROFILES
2.1 Active Motif
2.1.1 Active Motif Details
2.1.2 Active Motif Major Business
2.1.3 Active Motif RNA Modifying Agents Product and Services
2.1.4 Active Motif RNA Modifying Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Active Motif Recent Developments/Updates
2.2 Epigentek
2.2.1 Epigentek Details
2.2.2 Epigentek Major Business
2.2.3 Epigentek RNA Modifying Agents Product and Services
2.2.4 Epigentek RNA Modifying Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Epigentek Recent Developments/Updates
2.3 Thermo Fisher Scientific
2.3.1 Thermo Fisher Scientific Details
2.3.2 Thermo Fisher Scientific Major Business
2.3.3 Thermo Fisher Scientific RNA Modifying Agents Product and Services
2.3.4 Thermo Fisher Scientific RNA Modifying Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Thermo Fisher Scientific Recent Developments/Updates
2.4 Merck
2.4.1 Merck Details
2.4.2 Merck Major Business
2.4.3 Merck RNA Modifying Agents Product and Services
2.4.4 Merck RNA Modifying Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Merck Recent Developments/Updates
2.5 Gene Link
2.5.1 Gene Link Details
2.5.2 Gene Link Major Business
2.5.3 Gene Link RNA Modifying Agents Product and Services
2.5.4 Gene Link RNA Modifying Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Gene Link Recent Developments/Updates
2.6 abcam
2.6.1 abcam Details
2.6.2 abcam Major Business
2.6.3 abcam RNA Modifying Agents Product and Services
2.6.4 abcam RNA Modifying Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 abcam Recent Developments/Updates
2.7 ABclonal
2.7.1 ABclonal Details
2.7.2 ABclonal Major Business
2.7.3 ABclonal RNA Modifying Agents Product and Services
2.7.4 ABclonal RNA Modifying Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 ABclonal Recent Developments/Updates
2.8 MyBioSource
2.8.1 MyBioSource Details
2.8.2 MyBioSource Major Business
2.8.3 MyBioSource RNA Modifying Agents Product and Services
2.8.4 MyBioSource RNA Modifying Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 MyBioSource Recent Developments/Updates
2.9 Beyotime
2.9.1 Beyotime Details
2.9.2 Beyotime Major Business
2.9.3 Beyotime RNA Modifying Agents Product and Services
2.9.4 Beyotime RNA Modifying Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 Beyotime Recent Developments/Updates
2.10 Hologic
2.10.1 Hologic Details
2.10.2 Hologic Major Business
2.10.3 Hologic RNA Modifying Agents Product and Services
2.10.4 Hologic RNA Modifying Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 Hologic Recent Developments/Updates
2.11 Synaptic Systems
2.11.1 Synaptic Systems Details
2.11.2 Synaptic Systems Major Business
2.11.3 Synaptic Systems RNA Modifying Agents Product and Services
2.11.4 Synaptic Systems RNA Modifying Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 Synaptic Systems Recent Developments/Updates
2.12 Novus Biologicals
2.12.1 Novus Biologicals Details
2.12.2 Novus Biologicals Major Business
2.12.3 Novus Biologicals RNA Modifying Agents Product and Services
2.12.4 Novus Biologicals RNA Modifying Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 Novus Biologicals Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: RNA MODIFYING AGENTS BY MANUFACTURER
3.1 Global RNA Modifying Agents Sales Quantity by Manufacturer (2020-2025)
3.2 Global RNA Modifying Agents Revenue by Manufacturer (2020-2025)
3.3 Global RNA Modifying Agents Average Price by Manufacturer (2020-2025)
3.4 Market Share Analysis (2024)
3.4.1 Producer Shipments of RNA Modifying Agents by Manufacturer Revenue ($MM) and Market Share (%): 2024
3.4.2 Top 3 RNA Modifying Agents Manufacturer Market Share in 2024
3.4.3 Top 6 RNA Modifying Agents Manufacturer Market Share in 2024
3.5 RNA Modifying Agents Market: Overall Company Footprint Analysis
3.5.1 RNA Modifying Agents Market: Region Footprint
3.5.2 RNA Modifying Agents Market: Company Product Type Footprint
3.5.3 RNA Modifying Agents Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global RNA Modifying Agents Market Size by Region
4.1.1 Global RNA Modifying Agents Sales Quantity by Region (2020-2031)
4.1.2 Global RNA Modifying Agents Consumption Value by Region (2020-2031)
4.1.3 Global RNA Modifying Agents Average Price by Region (2020-2031)
4.2 North America RNA Modifying Agents Consumption Value (2020-2031)
4.3 Europe RNA Modifying Agents Consumption Value (2020-2031)
4.4 Asia-Pacific RNA Modifying Agents Consumption Value (2020-2031)
4.5 South America RNA Modifying Agents Consumption Value (2020-2031)
4.6 Middle East & Africa RNA Modifying Agents Consumption Value (2020-2031)
5 MARKET SEGMENT BY TYPE
5.1 Global RNA Modifying Agents Sales Quantity by Type (2020-2031)
5.2 Global RNA Modifying Agents Consumption Value by Type (2020-2031)
5.3 Global RNA Modifying Agents Average Price by Type (2020-2031)
6 MARKET SEGMENT BY APPLICATION
6.1 Global RNA Modifying Agents Sales Quantity by Application (2020-2031)
6.2 Global RNA Modifying Agents Consumption Value by Application (2020-2031)
6.3 Global RNA Modifying Agents Average Price by Application (2020-2031)
7 NORTH AMERICA
7.1 North America RNA Modifying Agents Sales Quantity by Type (2020-2031)
7.2 North America RNA Modifying Agents Sales Quantity by Application (2020-2031)
7.3 North America RNA Modifying Agents Market Size by Country
7.3.1 North America RNA Modifying Agents Sales Quantity by Country (2020-2031)
7.3.2 North America RNA Modifying Agents Consumption Value by Country (2020-2031)
7.3.3 United States Market Size and Forecast (2020-2031)
7.3.4 Canada Market Size and Forecast (2020-2031)
7.3.5 Mexico Market Size and Forecast (2020-2031)
8 EUROPE
8.1 Europe RNA Modifying Agents Sales Quantity by Type (2020-2031)
8.2 Europe RNA Modifying Agents Sales Quantity by Application (2020-2031)
8.3 Europe RNA Modifying Agents Market Size by Country
8.3.1 Europe RNA Modifying Agents Sales Quantity by Country (2020-2031)
8.3.2 Europe RNA Modifying Agents Consumption Value by Country (2020-2031)
8.3.3 Germany Market Size and Forecast (2020-2031)
8.3.4 France Market Size and Forecast (2020-2031)
8.3.5 United Kingdom Market Size and Forecast (2020-2031)
8.3.6 Russia Market Size and Forecast (2020-2031)
8.3.7 Italy Market Size and Forecast (2020-2031)
9 ASIA-PACIFIC
9.1 Asia-Pacific RNA Modifying Agents Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific RNA Modifying Agents Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific RNA Modifying Agents Market Size by Region
9.3.1 Asia-Pacific RNA Modifying Agents Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific RNA Modifying Agents Consumption Value by Region (2020-2031)
9.3.3 China Market Size and Forecast (2020-2031)
9.3.4 Japan Market Size and Forecast (2020-2031)
9.3.5 South Korea Market Size and Forecast (2020-2031)
9.3.6 India Market Size and Forecast (2020-2031)
9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
9.3.8 Australia Market Size and Forecast (2020-2031)
10 SOUTH AMERICA
10.1 South America RNA Modifying Agents Sales Quantity by Type (2020-2031)
10.2 South America RNA Modifying Agents Sales Quantity by Application (2020-2031)
10.3 South America RNA Modifying Agents Market Size by Country
10.3.1 South America RNA Modifying Agents Sales Quantity by Country (2020-2031)
10.3.2 South America RNA Modifying Agents Consumption Value by Country (2020-2031)
10.3.3 Brazil Market Size and Forecast (2020-2031)
10.3.4 Argentina Market Size and Forecast (2020-2031)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa RNA Modifying Agents Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa RNA Modifying Agents Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa RNA Modifying Agents Market Size by Country
11.3.1 Middle East & Africa RNA Modifying Agents Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa RNA Modifying Agents Consumption Value by Country (2020-2031)
11.3.3 Turkey Market Size and Forecast (2020-2031)
11.3.4 Egypt Market Size and Forecast (2020-2031)
11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
11.3.6 South Africa Market Size and Forecast (2020-2031)
12 MARKET DYNAMICS
12.1 RNA Modifying Agents Market Drivers
12.2 RNA Modifying Agents Market Restraints
12.3 RNA Modifying Agents Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of RNA Modifying Agents and Key Manufacturers
13.2 Manufacturing Costs Percentage of RNA Modifying Agents
13.3 RNA Modifying Agents Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 RNA Modifying Agents Typical Distributors
14.3 RNA Modifying Agents Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global RNA Modifying Agents Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global RNA Modifying Agents Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Active Motif Basic Information, Manufacturing Base and Competitors
Table 4. Active Motif Major Business
Table 5. Active Motif RNA Modifying Agents Product and Services
Table 6. Active Motif RNA Modifying Agents Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 7. Active Motif Recent Developments/Updates
Table 8. Epigentek Basic Information, Manufacturing Base and Competitors
Table 9. Epigentek Major Business
Table 10. Epigentek RNA Modifying Agents Product and Services
Table 11. Epigentek RNA Modifying Agents Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 12. Epigentek Recent Developments/Updates
Table 13. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table 14. Thermo Fisher Scientific Major Business
Table 15. Thermo Fisher Scientific RNA Modifying Agents Product and Services
Table 16. Thermo Fisher Scientific RNA Modifying Agents Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 17. Thermo Fisher Scientific Recent Developments/Updates
Table 18. Merck Basic Information, Manufacturing Base and Competitors
Table 19. Merck Major Business
Table 20. Merck RNA Modifying Agents Product and Services
Table 21. Merck RNA Modifying Agents Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 22. Merck Recent Developments/Updates
Table 23. Gene Link Basic Information, Manufacturing Base and Competitors
Table 24. Gene Link Major Business
Table 25. Gene Link RNA Modifying Agents Product and Services
Table 26. Gene Link RNA Modifying Agents Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 27. Gene Link Recent Developments/Updates
Table 28. abcam Basic Information, Manufacturing Base and Competitors
Table 29. abcam Major Business
Table 30. abcam RNA Modifying Agents Product and Services
Table 31. abcam RNA Modifying Agents Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 32. abcam Recent Developments/Updates
Table 33. ABclonal Basic Information, Manufacturing Base and Competitors
Table 34. ABclonal Major Business
Table 35. ABclonal RNA Modifying Agents Product and Services
Table 36. ABclonal RNA Modifying Agents Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 37. ABclonal Recent Developments/Updates
Table 38. MyBioSource Basic Information, Manufacturing Base and Competitors
Table 39. MyBioSource Major Business
Table 40. MyBioSource RNA Modifying Agents Product and Services
Table 41. MyBioSource RNA Modifying Agents Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 42. MyBioSource Recent Developments/Updates
Table 43. Beyotime Basic Information, Manufacturing Base and Competitors
Table 44. Beyotime Major Business
Table 45. Beyotime RNA Modifying Agents Product and Services
Table 46. Beyotime RNA Modifying Agents Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 47. Beyotime Recent Developments/Updates
Table 48. Hologic Basic Information, Manufacturing Base and Competitors
Table 49. Hologic Major Business
Table 50. Hologic RNA Modifying Agents Product and Services
Table 51. Hologic RNA Modifying Agents Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 52. Hologic Recent Developments/Updates
Table 53. Synaptic Systems Basic Information, Manufacturing Base and Competitors
Table 54. Synaptic Systems Major Business
Table 55. Synaptic Systems RNA Modifying Agents Product and Services
Table 56. Synaptic Systems RNA Modifying Agents Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 57. Synaptic Systems Recent Developments/Updates
Table 58. Novus Biologicals Basic Information, Manufacturing Base and Competitors
Table 59. Novus Biologicals Major Business
Table 60. Novus Biologicals RNA Modifying Agents Product and Services
Table 61. Novus Biologicals RNA Modifying Agents Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 62. Novus Biologicals Recent Developments/Updates
Table 63. Global RNA Modifying Agents Sales Quantity by Manufacturer (2020-2025) & (K Units)
Table 64. Global RNA Modifying Agents Revenue by Manufacturer (2020-2025) & (USD Million)
Table 65. Global RNA Modifying Agents Average Price by Manufacturer (2020-2025) & (US$/Unit)
Table 66. Market Position of Manufacturers in RNA Modifying Agents, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 67. Head Office and RNA Modifying Agents Production Site of Key Manufacturer
Table 68. RNA Modifying Agents Market: Company Product Type Footprint
Table 69. RNA Modifying Agents Market: Company Product Application Footprint
Table 70. RNA Modifying Agents New Market Entrants and Barriers to Market Entry
Table 71. RNA Modifying Agents Mergers, Acquisition, Agreements, and Collaborations
Table 72. Global RNA Modifying Agents Consumption Value by Region (2020-2024-2031) & (USD Million) & CAGR
Table 73. Global RNA Modifying Agents Sales Quantity by Region (2020-2025) & (K Units)
Table 74. Global RNA Modifying Agents Sales Quantity by Region (2026-2031) & (K Units)
Table 75. Global RNA Modifying Agents Consumption Value by Region (2020-2025) & (USD Million)
Table 76. Global RNA Modifying Agents Consumption Value by Region (2026-2031) & (USD Million)
Table 77. Global RNA Modifying Agents Average Price by Region (2020-2025) & (US$/Unit)
Table 78. Global RNA Modifying Agents Average Price by Region (2026-2031) & (US$/Unit)
Table 79. Global RNA Modifying Agents Sales Quantity by Type (2020-2025) & (K Units)
Table 80. Global RNA Modifying Agents Sales Quantity by Type (2026-2031) & (K Units)
Table 81. Global RNA Modifying Agents Consumption Value by Type (2020-2025) & (USD Million)
Table 82. Global RNA Modifying Agents Consumption Value by Type (2026-2031) & (USD Million)
Table 83. Global RNA Modifying Agents Average Price by Type (2020-2025) & (US$/Unit)
Table 84. Global RNA Modifying Agents Average Price by Type (2026-2031) & (US$/Unit)
Table 85. Global RNA Modifying Agents Sales Quantity by Application (2020-2025) & (K Units)
Table 86. Global RNA Modifying Agents Sales Quantity by Application (2026-2031) & (K Units)
Table 87. Global RNA Modifying Agents Consumption Value by Application (2020-2025) & (USD Million)
Table 88. Global RNA Modifying Agents Consumption Value by Application (2026-2031) & (USD Million)
Table 89. Global RNA Modifying Agents Average Price by Application (2020-2025) & (US$/Unit)
Table 90. Global RNA Modifying Agents Average Price by Application (2026-2031) & (US$/Unit)
Table 91. North America RNA Modifying Agents Sales Quantity by Type (2020-2025) & (K Units)
Table 92. North America RNA Modifying Agents Sales Quantity by Type (2026-2031) & (K Units)
Table 93. North America RNA Modifying Agents Sales Quantity by Application (2020-2025) & (K Units)
Table 94. North America RNA Modifying Agents Sales Quantity by Application (2026-2031) & (K Units)
Table 95. North America RNA Modifying Agents Sales Quantity by Country (2020-2025) & (K Units)
Table 96. North America RNA Modifying Agents Sales Quantity by Country (2026-2031) & (K Units)
Table 97. North America RNA Modifying Agents Consumption Value by Country (2020-2025) & (USD Million)
Table 98. North America RNA Modifying Agents Consumption Value by Country (2026-2031) & (USD Million)
Table 99. Europe RNA Modifying Agents Sales Quantity by Type (2020-2025) & (K Units)
Table 100. Europe RNA Modifying Agents Sales Quantity by Type (2026-2031) & (K Units)
Table 101. Europe RNA Modifying Agents Sales Quantity by Application (2020-2025) & (K Units)
Table 102. Europe RNA Modifying Agents Sales Quantity by Application (2026-2031) & (K Units)
Table 103. Europe RNA Modifying Agents Sales Quantity by Country (2020-2025) & (K Units)
Table 104. Europe RNA Modifying Agents Sales Quantity by Country (2026-2031) & (K Units)
Table 105. Europe RNA Modifying Agents Consumption Value by Country (2020-2025) & (USD Million)
Table 106. Europe RNA Modifying Agents Consumption Value by Country (2026-2031) & (USD Million)
Table 107. Asia-Pacific RNA Modifying Agents Sales Quantity by Type (2020-2025) & (K Units)
Table 108. Asia-Pacific RNA Modifying Agents Sales Quantity by Type (2026-2031) & (K Units)
Table 109. Asia-Pacific RNA Modifying Agents Sales Quantity by Application (2020-2025) & (K Units)
Table 110. Asia-Pacific RNA Modifying Agents Sales Quantity by Application (2026-2031) & (K Units)
Table 111. Asia-Pacific RNA Modifying Agents Sales Quantity by Region (2020-2025) & (K Units)
Table 112. Asia-Pacific RNA Modifying Agents Sales Quantity by Region (2026-2031) & (K Units)
Table 113. Asia-Pacific RNA Modifying Agents Consumption Value by Region (2020-2025) & (USD Million)
Table 114. Asia-Pacific RNA Modifying Agents Consumption Value by Region (2026-2031) & (USD Million)
Table 115. South America RNA Modifying Agents Sales Quantity by Type (2020-2025) & (K Units)
Table 116. South America RNA Modifying Agents Sales Quantity by Type (2026-2031) & (K Units)
Table 117. South America RNA Modifying Agents Sales Quantity by Application (2020-2025) & (K Units)
Table 118. South America RNA Modifying Agents Sales Quantity by Application (2026-2031) & (K Units)
Table 119. South America RNA Modifying Agents Sales Quantity by Country (2020-2025) & (K Units)
Table 120. South America RNA Modifying Agents Sales Quantity by Country (2026-2031) & (K Units)
Table 121. South America RNA Modifying Agents Consumption Value by Country (2020-2025) & (USD Million)
Table 122. South America RNA Modifying Agents Consumption Value by Country (2026-2031) & (USD Million)
Table 123. Middle East & Africa RNA Modifying Agents Sales Quantity by Type (2020-2025) & (K Units)
Table 124. Middle East & Africa RNA Modifying Agents Sales Quantity by Type (2026-2031) & (K Units)
Table 125. Middle East & Africa RNA Modifying Agents Sales Quantity by Application (2020-2025) & (K Units)
Table 126. Middle East & Africa RNA Modifying Agents Sales Quantity by Application (2026-2031) & (K Units)
Table 127. Middle East & Africa RNA Modifying Agents Sales Quantity by Country (2020-2025) & (K Units)
Table 128. Middle East & Africa RNA Modifying Agents Sales Quantity by Country (2026-2031) & (K Units)
Table 129. Middle East & Africa RNA Modifying Agents Consumption Value by Country (2020-2025) & (USD Million)
Table 130. Middle East & Africa RNA Modifying Agents Consumption Value by Country (2026-2031) & (USD Million)
Table 131. RNA Modifying Agents Raw Material
Table 132. Key Manufacturers of RNA Modifying Agents Raw Materials
Table 133. RNA Modifying Agents Typical Distributors
Table 134. RNA Modifying Agents Typical Customers
Table 1. Global RNA Modifying Agents Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global RNA Modifying Agents Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Active Motif Basic Information, Manufacturing Base and Competitors
Table 4. Active Motif Major Business
Table 5. Active Motif RNA Modifying Agents Product and Services
Table 6. Active Motif RNA Modifying Agents Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 7. Active Motif Recent Developments/Updates
Table 8. Epigentek Basic Information, Manufacturing Base and Competitors
Table 9. Epigentek Major Business
Table 10. Epigentek RNA Modifying Agents Product and Services
Table 11. Epigentek RNA Modifying Agents Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 12. Epigentek Recent Developments/Updates
Table 13. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table 14. Thermo Fisher Scientific Major Business
Table 15. Thermo Fisher Scientific RNA Modifying Agents Product and Services
Table 16. Thermo Fisher Scientific RNA Modifying Agents Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 17. Thermo Fisher Scientific Recent Developments/Updates
Table 18. Merck Basic Information, Manufacturing Base and Competitors
Table 19. Merck Major Business
Table 20. Merck RNA Modifying Agents Product and Services
Table 21. Merck RNA Modifying Agents Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 22. Merck Recent Developments/Updates
Table 23. Gene Link Basic Information, Manufacturing Base and Competitors
Table 24. Gene Link Major Business
Table 25. Gene Link RNA Modifying Agents Product and Services
Table 26. Gene Link RNA Modifying Agents Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 27. Gene Link Recent Developments/Updates
Table 28. abcam Basic Information, Manufacturing Base and Competitors
Table 29. abcam Major Business
Table 30. abcam RNA Modifying Agents Product and Services
Table 31. abcam RNA Modifying Agents Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 32. abcam Recent Developments/Updates
Table 33. ABclonal Basic Information, Manufacturing Base and Competitors
Table 34. ABclonal Major Business
Table 35. ABclonal RNA Modifying Agents Product and Services
Table 36. ABclonal RNA Modifying Agents Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 37. ABclonal Recent Developments/Updates
Table 38. MyBioSource Basic Information, Manufacturing Base and Competitors
Table 39. MyBioSource Major Business
Table 40. MyBioSource RNA Modifying Agents Product and Services
Table 41. MyBioSource RNA Modifying Agents Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 42. MyBioSource Recent Developments/Updates
Table 43. Beyotime Basic Information, Manufacturing Base and Competitors
Table 44. Beyotime Major Business
Table 45. Beyotime RNA Modifying Agents Product and Services
Table 46. Beyotime RNA Modifying Agents Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 47. Beyotime Recent Developments/Updates
Table 48. Hologic Basic Information, Manufacturing Base and Competitors
Table 49. Hologic Major Business
Table 50. Hologic RNA Modifying Agents Product and Services
Table 51. Hologic RNA Modifying Agents Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 52. Hologic Recent Developments/Updates
Table 53. Synaptic Systems Basic Information, Manufacturing Base and Competitors
Table 54. Synaptic Systems Major Business
Table 55. Synaptic Systems RNA Modifying Agents Product and Services
Table 56. Synaptic Systems RNA Modifying Agents Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 57. Synaptic Systems Recent Developments/Updates
Table 58. Novus Biologicals Basic Information, Manufacturing Base and Competitors
Table 59. Novus Biologicals Major Business
Table 60. Novus Biologicals RNA Modifying Agents Product and Services
Table 61. Novus Biologicals RNA Modifying Agents Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 62. Novus Biologicals Recent Developments/Updates
Table 63. Global RNA Modifying Agents Sales Quantity by Manufacturer (2020-2025) & (K Units)
Table 64. Global RNA Modifying Agents Revenue by Manufacturer (2020-2025) & (USD Million)
Table 65. Global RNA Modifying Agents Average Price by Manufacturer (2020-2025) & (US$/Unit)
Table 66. Market Position of Manufacturers in RNA Modifying Agents, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 67. Head Office and RNA Modifying Agents Production Site of Key Manufacturer
Table 68. RNA Modifying Agents Market: Company Product Type Footprint
Table 69. RNA Modifying Agents Market: Company Product Application Footprint
Table 70. RNA Modifying Agents New Market Entrants and Barriers to Market Entry
Table 71. RNA Modifying Agents Mergers, Acquisition, Agreements, and Collaborations
Table 72. Global RNA Modifying Agents Consumption Value by Region (2020-2024-2031) & (USD Million) & CAGR
Table 73. Global RNA Modifying Agents Sales Quantity by Region (2020-2025) & (K Units)
Table 74. Global RNA Modifying Agents Sales Quantity by Region (2026-2031) & (K Units)
Table 75. Global RNA Modifying Agents Consumption Value by Region (2020-2025) & (USD Million)
Table 76. Global RNA Modifying Agents Consumption Value by Region (2026-2031) & (USD Million)
Table 77. Global RNA Modifying Agents Average Price by Region (2020-2025) & (US$/Unit)
Table 78. Global RNA Modifying Agents Average Price by Region (2026-2031) & (US$/Unit)
Table 79. Global RNA Modifying Agents Sales Quantity by Type (2020-2025) & (K Units)
Table 80. Global RNA Modifying Agents Sales Quantity by Type (2026-2031) & (K Units)
Table 81. Global RNA Modifying Agents Consumption Value by Type (2020-2025) & (USD Million)
Table 82. Global RNA Modifying Agents Consumption Value by Type (2026-2031) & (USD Million)
Table 83. Global RNA Modifying Agents Average Price by Type (2020-2025) & (US$/Unit)
Table 84. Global RNA Modifying Agents Average Price by Type (2026-2031) & (US$/Unit)
Table 85. Global RNA Modifying Agents Sales Quantity by Application (2020-2025) & (K Units)
Table 86. Global RNA Modifying Agents Sales Quantity by Application (2026-2031) & (K Units)
Table 87. Global RNA Modifying Agents Consumption Value by Application (2020-2025) & (USD Million)
Table 88. Global RNA Modifying Agents Consumption Value by Application (2026-2031) & (USD Million)
Table 89. Global RNA Modifying Agents Average Price by Application (2020-2025) & (US$/Unit)
Table 90. Global RNA Modifying Agents Average Price by Application (2026-2031) & (US$/Unit)
Table 91. North America RNA Modifying Agents Sales Quantity by Type (2020-2025) & (K Units)
Table 92. North America RNA Modifying Agents Sales Quantity by Type (2026-2031) & (K Units)
Table 93. North America RNA Modifying Agents Sales Quantity by Application (2020-2025) & (K Units)
Table 94. North America RNA Modifying Agents Sales Quantity by Application (2026-2031) & (K Units)
Table 95. North America RNA Modifying Agents Sales Quantity by Country (2020-2025) & (K Units)
Table 96. North America RNA Modifying Agents Sales Quantity by Country (2026-2031) & (K Units)
Table 97. North America RNA Modifying Agents Consumption Value by Country (2020-2025) & (USD Million)
Table 98. North America RNA Modifying Agents Consumption Value by Country (2026-2031) & (USD Million)
Table 99. Europe RNA Modifying Agents Sales Quantity by Type (2020-2025) & (K Units)
Table 100. Europe RNA Modifying Agents Sales Quantity by Type (2026-2031) & (K Units)
Table 101. Europe RNA Modifying Agents Sales Quantity by Application (2020-2025) & (K Units)
Table 102. Europe RNA Modifying Agents Sales Quantity by Application (2026-2031) & (K Units)
Table 103. Europe RNA Modifying Agents Sales Quantity by Country (2020-2025) & (K Units)
Table 104. Europe RNA Modifying Agents Sales Quantity by Country (2026-2031) & (K Units)
Table 105. Europe RNA Modifying Agents Consumption Value by Country (2020-2025) & (USD Million)
Table 106. Europe RNA Modifying Agents Consumption Value by Country (2026-2031) & (USD Million)
Table 107. Asia-Pacific RNA Modifying Agents Sales Quantity by Type (2020-2025) & (K Units)
Table 108. Asia-Pacific RNA Modifying Agents Sales Quantity by Type (2026-2031) & (K Units)
Table 109. Asia-Pacific RNA Modifying Agents Sales Quantity by Application (2020-2025) & (K Units)
Table 110. Asia-Pacific RNA Modifying Agents Sales Quantity by Application (2026-2031) & (K Units)
Table 111. Asia-Pacific RNA Modifying Agents Sales Quantity by Region (2020-2025) & (K Units)
Table 112. Asia-Pacific RNA Modifying Agents Sales Quantity by Region (2026-2031) & (K Units)
Table 113. Asia-Pacific RNA Modifying Agents Consumption Value by Region (2020-2025) & (USD Million)
Table 114. Asia-Pacific RNA Modifying Agents Consumption Value by Region (2026-2031) & (USD Million)
Table 115. South America RNA Modifying Agents Sales Quantity by Type (2020-2025) & (K Units)
Table 116. South America RNA Modifying Agents Sales Quantity by Type (2026-2031) & (K Units)
Table 117. South America RNA Modifying Agents Sales Quantity by Application (2020-2025) & (K Units)
Table 118. South America RNA Modifying Agents Sales Quantity by Application (2026-2031) & (K Units)
Table 119. South America RNA Modifying Agents Sales Quantity by Country (2020-2025) & (K Units)
Table 120. South America RNA Modifying Agents Sales Quantity by Country (2026-2031) & (K Units)
Table 121. South America RNA Modifying Agents Consumption Value by Country (2020-2025) & (USD Million)
Table 122. South America RNA Modifying Agents Consumption Value by Country (2026-2031) & (USD Million)
Table 123. Middle East & Africa RNA Modifying Agents Sales Quantity by Type (2020-2025) & (K Units)
Table 124. Middle East & Africa RNA Modifying Agents Sales Quantity by Type (2026-2031) & (K Units)
Table 125. Middle East & Africa RNA Modifying Agents Sales Quantity by Application (2020-2025) & (K Units)
Table 126. Middle East & Africa RNA Modifying Agents Sales Quantity by Application (2026-2031) & (K Units)
Table 127. Middle East & Africa RNA Modifying Agents Sales Quantity by Country (2020-2025) & (K Units)
Table 128. Middle East & Africa RNA Modifying Agents Sales Quantity by Country (2026-2031) & (K Units)
Table 129. Middle East & Africa RNA Modifying Agents Consumption Value by Country (2020-2025) & (USD Million)
Table 130. Middle East & Africa RNA Modifying Agents Consumption Value by Country (2026-2031) & (USD Million)
Table 131. RNA Modifying Agents Raw Material
Table 132. Key Manufacturers of RNA Modifying Agents Raw Materials
Table 133. RNA Modifying Agents Typical Distributors
Table 134. RNA Modifying Agents Typical Customers
LIST OF FIGURES
Figure 1. RNA Modifying Agents Picture
Figure 2. Global RNA Modifying Agents Revenue by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global RNA Modifying Agents Revenue Market Share by Type in 2024
Figure 4. N6-Methyladenosine (m6A) Antibody Examples
Figure 5. 5-Methylcytosine (5-mC) Antibody Examples
Figure 6. Others Examples
Figure 7. Global RNA Modifying Agents Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 8. Global RNA Modifying Agents Revenue Market Share by Application in 2024
Figure 9. Gene Therapy Examples
Figure 10. Cancer Research Examples
Figure 11. Drug Development Examples
Figure 12. Other Examples
Figure 13. Global RNA Modifying Agents Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 14. Global RNA Modifying Agents Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 15. Global RNA Modifying Agents Sales Quantity (2020-2031) & (K Units)
Figure 16. Global RNA Modifying Agents Price (2020-2031) & (US$/Unit)
Figure 17. Global RNA Modifying Agents Sales Quantity Market Share by Manufacturer in 2024
Figure 18. Global RNA Modifying Agents Revenue Market Share by Manufacturer in 2024
Figure 19. Producer Shipments of RNA Modifying Agents by Manufacturer Sales ($MM) and Market Share (%): 2024
Figure 20. Top 3 RNA Modifying Agents Manufacturer (Revenue) Market Share in 2024
Figure 21. Top 6 RNA Modifying Agents Manufacturer (Revenue) Market Share in 2024
Figure 22. Global RNA Modifying Agents Sales Quantity Market Share by Region (2020-2031)
Figure 23. Global RNA Modifying Agents Consumption Value Market Share by Region (2020-2031)
Figure 24. North America RNA Modifying Agents Consumption Value (2020-2031) & (USD Million)
Figure 25. Europe RNA Modifying Agents Consumption Value (2020-2031) & (USD Million)
Figure 26. Asia-Pacific RNA Modifying Agents Consumption Value (2020-2031) & (USD Million)
Figure 27. South America RNA Modifying Agents Consumption Value (2020-2031) & (USD Million)
Figure 28. Middle East & Africa RNA Modifying Agents Consumption Value (2020-2031) & (USD Million)
Figure 29. Global RNA Modifying Agents Sales Quantity Market Share by Type (2020-2031)
Figure 30. Global RNA Modifying Agents Consumption Value Market Share by Type (2020-2031)
Figure 31. Global RNA Modifying Agents Average Price by Type (2020-2031) & (US$/Unit)
Figure 32. Global RNA Modifying Agents Sales Quantity Market Share by Application (2020-2031)
Figure 33. Global RNA Modifying Agents Revenue Market Share by Application (2020-2031)
Figure 34. Global RNA Modifying Agents Average Price by Application (2020-2031) & (US$/Unit)
Figure 35. North America RNA Modifying Agents Sales Quantity Market Share by Type (2020-2031)
Figure 36. North America RNA Modifying Agents Sales Quantity Market Share by Application (2020-2031)
Figure 37. North America RNA Modifying Agents Sales Quantity Market Share by Country (2020-2031)
Figure 38. North America RNA Modifying Agents Consumption Value Market Share by Country (2020-2031)
Figure 39. United States RNA Modifying Agents Consumption Value (2020-2031) & (USD Million)
Figure 40. Canada RNA Modifying Agents Consumption Value (2020-2031) & (USD Million)
Figure 41. Mexico RNA Modifying Agents Consumption Value (2020-2031) & (USD Million)
Figure 42. Europe RNA Modifying Agents Sales Quantity Market Share by Type (2020-2031)
Figure 43. Europe RNA Modifying Agents Sales Quantity Market Share by Application (2020-2031)
Figure 44. Europe RNA Modifying Agents Sales Quantity Market Share by Country (2020-2031)
Figure 45. Europe RNA Modifying Agents Consumption Value Market Share by Country (2020-2031)
Figure 46. Germany RNA Modifying Agents Consumption Value (2020-2031) & (USD Million)
Figure 47. France RNA Modifying Agents Consumption Value (2020-2031) & (USD Million)
Figure 48. United Kingdom RNA Modifying Agents Consumption Value (2020-2031) & (USD Million)
Figure 49. Russia RNA Modifying Agents Consumption Value (2020-2031) & (USD Million)
Figure 50. Italy RNA Modifying Agents Consumption Value (2020-2031) & (USD Million)
Figure 51. Asia-Pacific RNA Modifying Agents Sales Quantity Market Share by Type (2020-2031)
Figure 52. Asia-Pacific RNA Modifying Agents Sales Quantity Market Share by Application (2020-2031)
Figure 53. Asia-Pacific RNA Modifying Agents Sales Quantity Market Share by Region (2020-2031)
Figure 54. Asia-Pacific RNA Modifying Agents Consumption Value Market Share by Region (2020-2031)
Figure 55. China RNA Modifying Agents Consumption Value (2020-2031) & (USD Million)
Figure 56. Japan RNA Modifying Agents Consumption Value (2020-2031) & (USD Million)
Figure 57. South Korea RNA Modifying Agents Consumption Value (2020-2031) & (USD Million)
Figure 58. India RNA Modifying Agents Consumption Value (2020-2031) & (USD Million)
Figure 59. Southeast Asia RNA Modifying Agents Consumption Value (2020-2031) & (USD Million)
Figure 60. Australia RNA Modifying Agents Consumption Value (2020-2031) & (USD Million)
Figure 61. South America RNA Modifying Agents Sales Quantity Market Share by Type (2020-2031)
Figure 62. South America RNA Modifying Agents Sales Quantity Market Share by Application (2020-2031)
Figure 63. South America RNA Modifying Agents Sales Quantity Market Share by Country (2020-2031)
Figure 64. South America RNA Modifying Agents Consumption Value Market Share by Country (2020-2031)
Figure 65. Brazil RNA Modifying Agents Consumption Value (2020-2031) & (USD Million)
Figure 66. Argentina RNA Modifying Agents Consumption Value (2020-2031) & (USD Million)
Figure 67. Middle East & Africa RNA Modifying Agents Sales Quantity Market Share by Type (2020-2031)
Figure 68. Middle East & Africa RNA Modifying Agents Sales Quantity Market Share by Application (2020-2031)
Figure 69. Middle East & Africa RNA Modifying Agents Sales Quantity Market Share by Country (2020-2031)
Figure 70. Middle East & Africa RNA Modifying Agents Consumption Value Market Share by Country (2020-2031)
Figure 71. Turkey RNA Modifying Agents Consumption Value (2020-2031) & (USD Million)
Figure 72. Egypt RNA Modifying Agents Consumption Value (2020-2031) & (USD Million)
Figure 73. Saudi Arabia RNA Modifying Agents Consumption Value (2020-2031) & (USD Million)
Figure 74. South Africa RNA Modifying Agents Consumption Value (2020-2031) & (USD Million)
Figure 75. RNA Modifying Agents Market Drivers
Figure 76. RNA Modifying Agents Market Restraints
Figure 77. RNA Modifying Agents Market Trends
Figure 78. Porters Five Forces Analysis
Figure 79. Manufacturing Cost Structure Analysis of RNA Modifying Agents in 2024
Figure 80. Manufacturing Process Analysis of RNA Modifying Agents
Figure 81. RNA Modifying Agents Industrial Chain
Figure 82. Sales Channel: Direct to End-User vs Distributors
Figure 83. Direct Channel Pros & Cons
Figure 84. Indirect Channel Pros & Cons
Figure 85. Methodology
Figure 86. Research Process and Data Source
Figure 1. RNA Modifying Agents Picture
Figure 2. Global RNA Modifying Agents Revenue by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global RNA Modifying Agents Revenue Market Share by Type in 2024
Figure 4. N6-Methyladenosine (m6A) Antibody Examples
Figure 5. 5-Methylcytosine (5-mC) Antibody Examples
Figure 6. Others Examples
Figure 7. Global RNA Modifying Agents Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 8. Global RNA Modifying Agents Revenue Market Share by Application in 2024
Figure 9. Gene Therapy Examples
Figure 10. Cancer Research Examples
Figure 11. Drug Development Examples
Figure 12. Other Examples
Figure 13. Global RNA Modifying Agents Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 14. Global RNA Modifying Agents Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 15. Global RNA Modifying Agents Sales Quantity (2020-2031) & (K Units)
Figure 16. Global RNA Modifying Agents Price (2020-2031) & (US$/Unit)
Figure 17. Global RNA Modifying Agents Sales Quantity Market Share by Manufacturer in 2024
Figure 18. Global RNA Modifying Agents Revenue Market Share by Manufacturer in 2024
Figure 19. Producer Shipments of RNA Modifying Agents by Manufacturer Sales ($MM) and Market Share (%): 2024
Figure 20. Top 3 RNA Modifying Agents Manufacturer (Revenue) Market Share in 2024
Figure 21. Top 6 RNA Modifying Agents Manufacturer (Revenue) Market Share in 2024
Figure 22. Global RNA Modifying Agents Sales Quantity Market Share by Region (2020-2031)
Figure 23. Global RNA Modifying Agents Consumption Value Market Share by Region (2020-2031)
Figure 24. North America RNA Modifying Agents Consumption Value (2020-2031) & (USD Million)
Figure 25. Europe RNA Modifying Agents Consumption Value (2020-2031) & (USD Million)
Figure 26. Asia-Pacific RNA Modifying Agents Consumption Value (2020-2031) & (USD Million)
Figure 27. South America RNA Modifying Agents Consumption Value (2020-2031) & (USD Million)
Figure 28. Middle East & Africa RNA Modifying Agents Consumption Value (2020-2031) & (USD Million)
Figure 29. Global RNA Modifying Agents Sales Quantity Market Share by Type (2020-2031)
Figure 30. Global RNA Modifying Agents Consumption Value Market Share by Type (2020-2031)
Figure 31. Global RNA Modifying Agents Average Price by Type (2020-2031) & (US$/Unit)
Figure 32. Global RNA Modifying Agents Sales Quantity Market Share by Application (2020-2031)
Figure 33. Global RNA Modifying Agents Revenue Market Share by Application (2020-2031)
Figure 34. Global RNA Modifying Agents Average Price by Application (2020-2031) & (US$/Unit)
Figure 35. North America RNA Modifying Agents Sales Quantity Market Share by Type (2020-2031)
Figure 36. North America RNA Modifying Agents Sales Quantity Market Share by Application (2020-2031)
Figure 37. North America RNA Modifying Agents Sales Quantity Market Share by Country (2020-2031)
Figure 38. North America RNA Modifying Agents Consumption Value Market Share by Country (2020-2031)
Figure 39. United States RNA Modifying Agents Consumption Value (2020-2031) & (USD Million)
Figure 40. Canada RNA Modifying Agents Consumption Value (2020-2031) & (USD Million)
Figure 41. Mexico RNA Modifying Agents Consumption Value (2020-2031) & (USD Million)
Figure 42. Europe RNA Modifying Agents Sales Quantity Market Share by Type (2020-2031)
Figure 43. Europe RNA Modifying Agents Sales Quantity Market Share by Application (2020-2031)
Figure 44. Europe RNA Modifying Agents Sales Quantity Market Share by Country (2020-2031)
Figure 45. Europe RNA Modifying Agents Consumption Value Market Share by Country (2020-2031)
Figure 46. Germany RNA Modifying Agents Consumption Value (2020-2031) & (USD Million)
Figure 47. France RNA Modifying Agents Consumption Value (2020-2031) & (USD Million)
Figure 48. United Kingdom RNA Modifying Agents Consumption Value (2020-2031) & (USD Million)
Figure 49. Russia RNA Modifying Agents Consumption Value (2020-2031) & (USD Million)
Figure 50. Italy RNA Modifying Agents Consumption Value (2020-2031) & (USD Million)
Figure 51. Asia-Pacific RNA Modifying Agents Sales Quantity Market Share by Type (2020-2031)
Figure 52. Asia-Pacific RNA Modifying Agents Sales Quantity Market Share by Application (2020-2031)
Figure 53. Asia-Pacific RNA Modifying Agents Sales Quantity Market Share by Region (2020-2031)
Figure 54. Asia-Pacific RNA Modifying Agents Consumption Value Market Share by Region (2020-2031)
Figure 55. China RNA Modifying Agents Consumption Value (2020-2031) & (USD Million)
Figure 56. Japan RNA Modifying Agents Consumption Value (2020-2031) & (USD Million)
Figure 57. South Korea RNA Modifying Agents Consumption Value (2020-2031) & (USD Million)
Figure 58. India RNA Modifying Agents Consumption Value (2020-2031) & (USD Million)
Figure 59. Southeast Asia RNA Modifying Agents Consumption Value (2020-2031) & (USD Million)
Figure 60. Australia RNA Modifying Agents Consumption Value (2020-2031) & (USD Million)
Figure 61. South America RNA Modifying Agents Sales Quantity Market Share by Type (2020-2031)
Figure 62. South America RNA Modifying Agents Sales Quantity Market Share by Application (2020-2031)
Figure 63. South America RNA Modifying Agents Sales Quantity Market Share by Country (2020-2031)
Figure 64. South America RNA Modifying Agents Consumption Value Market Share by Country (2020-2031)
Figure 65. Brazil RNA Modifying Agents Consumption Value (2020-2031) & (USD Million)
Figure 66. Argentina RNA Modifying Agents Consumption Value (2020-2031) & (USD Million)
Figure 67. Middle East & Africa RNA Modifying Agents Sales Quantity Market Share by Type (2020-2031)
Figure 68. Middle East & Africa RNA Modifying Agents Sales Quantity Market Share by Application (2020-2031)
Figure 69. Middle East & Africa RNA Modifying Agents Sales Quantity Market Share by Country (2020-2031)
Figure 70. Middle East & Africa RNA Modifying Agents Consumption Value Market Share by Country (2020-2031)
Figure 71. Turkey RNA Modifying Agents Consumption Value (2020-2031) & (USD Million)
Figure 72. Egypt RNA Modifying Agents Consumption Value (2020-2031) & (USD Million)
Figure 73. Saudi Arabia RNA Modifying Agents Consumption Value (2020-2031) & (USD Million)
Figure 74. South Africa RNA Modifying Agents Consumption Value (2020-2031) & (USD Million)
Figure 75. RNA Modifying Agents Market Drivers
Figure 76. RNA Modifying Agents Market Restraints
Figure 77. RNA Modifying Agents Market Trends
Figure 78. Porters Five Forces Analysis
Figure 79. Manufacturing Cost Structure Analysis of RNA Modifying Agents in 2024
Figure 80. Manufacturing Process Analysis of RNA Modifying Agents
Figure 81. RNA Modifying Agents Industrial Chain
Figure 82. Sales Channel: Direct to End-User vs Distributors
Figure 83. Direct Channel Pros & Cons
Figure 84. Indirect Channel Pros & Cons
Figure 85. Methodology
Figure 86. Research Process and Data Source
